FAFO: Trump Erases Biden Era Drug Reduction Plan For Seniors
January 22, 2025

A new edition of FAFO has hit: Medication For Seniors!!!

A quick reminder. The Biden Administration enacted a slew of prescription drug cost reductions for seniors and citizens on Medicaid. The negotiated cuts would have saved Americans about $1.5 billion in out-of-pocket costs. The drugs treat a variety of serious illnesses, including diabetes, heart disease, arthritis and other ailments and the prices would have taken effect in 2026.

Medications covered would have included:

  • Januvia (Diabetes)
  • Fiasp ((Diabetes)
  • Farxiga (Diabetes, heart failure and chronic kidney disease)
  • Enbrel (Rheumatoid arthritis, psoriasis and psoriatic arthritis)
  • Jardiance (Diabetes, heart failure and chronic kidney disease)
  • Stelara (Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis)
  • Xarelto (Prevention and treatment of blood clots. Reduction of risk for patients with coronary or peripheral artery disease)
  • Eliquis (Prevention and treatment of blood clots)
  • Entresto (Heart failure)
  • Imbruvica (Blood cancers)

Well, bad news. Trump has sided with Big Pharma and Medicaid and rescinded this directive, which means all the costs will skyrocket again! MAGA! Or MAHA? Which one are we using now?

Anyhow, this was one of the roughly 100 executive orders and directives that Trump signed on day one of his Reign of Terror, Part 2. Congrats, you played yourself. Enjoy rationing your insulin and heart medicine. You owned the libs good!

Can you help us out?

For over 20 years we have been exposing Washington lies and untangling media deceit, but social media is limiting our ability to attract new readers. Please give a one-time or recurring donation, or buy a year's subscription for an ad-free experience. Thank you.

Discussion

We welcome relevant, respectful comments. Any comments that are sexist or in any other way deemed hateful by our staff will be deleted and constitute grounds for a ban from posting on the site. Please refer to our Terms of Service for information on our posting policy.
Mastodon